Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Related party transactions

v3.22.1
Related party transactions
12 Months Ended
Dec. 31, 2021
Related party transactions

 

10. Related party transactions

 

All related party transactions were measured at the amount of consideration established and agreed to by the related parties. All amounts due from/payable to related parties are unsecured, non-interest bearing and have no fixed terms of repayment.

 

During the year ended December 31, 2021, the Company incurred the following transactions with related parties:

 

a) Wages and benefits were paid or accrued to officers of the Company in the amount of $278,840 (2020 - $196,097; 2019 - $194,166).

 

b) Professional fees were paid or accrued to a former officer of the Company in the amount of $58,500 (2020 - $30,000; 2019 - $30,000).

 

c) Professional fees were paid or accrued to an officer of the Company in the amount of $53,000 (2020 -$Nil; 2019 - $Nil).

 

d) Research and development fees were paid or accrued to an officer of the Company in the amount of $106,366 (2020 - $Nil; 2019 - $Nil).

 

e) Consulting fees were accrued to directors of the Company in the amount of $34,950 (2020 - $36,000; 2019 - $Nil) and directors fees were accrued to the directors of the Company in the amount of $62,200 (2020 - $Nil; 2019 - $Nil).

 

f) As at December 31, 2021, $Nil (2020 - $52,450) was payable to the former Chief Financial Officer (“CFO”) of the Company for CFO services, and $81,104 (2020 - $20,340) was payable to directors of the Company, $25,000 (2020 - $518,084) was accrued to the Chief Executive Officer (“CEO”) of the Company, for CEO services, and $47,543 (2020 - $Nil) was accrued to the Chief Medical Officer (“CMO”) of the Company, for consulting services. The balances are unsecured, non-interest bearing, and have no fixed terms of repayment.

 

 

 

 

g) Management compensation transactions for the years ended December 31, 2021, 2020 and 2019 are summarized as follows:

 

   

Short-term

employee
benefits

   

Share-based payments

   

Total

 
      $       $       $  
Year ended December 31, 2019
Directors and officers
    224,166       29,646       253,812  
                         
Year ended December 31, 2020
Directors and officers
    262,097       217,816       479,913  
                         
Year ended December 31, 2021
Directors and officers
    593,856       331,809       925,665